2026 Healthcare M&A Report: EBITDA / SDE Valuation Multiples
The "Silver Tsunami" has officially arrived. As we move through 2026, the demand for home-based clinical services has transformed the healthcare M&A landscape into a high-stakes, high-multiple environment. For owners of Home Health agencies, Hospice platforms, and Private Duty firms, the window for a premium exit is wide open—but only for those who understand the new math of healthcare valuation when you sell your home care agency.
At Home Care Business Broker (HCBB), we specialize exclusively in the healthcare continuum. This guide breaks down the 2026 benchmarks for EBITDA and SDE multiples.
1. The Valuation Baseline: SDE vs. EBITDA
In healthcare, the transition from an SDE valuation to an EBITDA valuation is often triggered by "Clinical Autonomy"—the ability of the agency to pass a state survey or audit without the owner being the primary point of contact.
SDE (Seller’s Discretionary Earnings): Typical for agencies under $3M revenue where the owner still wears many hats.
2026 Benchmark: 3.0x – 4.0x.
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): For scaled agencies ($5M–$75M) with robust middle management.
2026 Benchmark: 6.5x – 12.0x+.
2. 2026 Sub-Industry Deep Dive
The "Payor Mix" (who pays you) is the single largest driver of your multiple.
Sub-Sector2026 Multiple RangeKey Value DriverMedicare Home Health7.5x – 9.5x EBITDA"Star Ratings" (4.5+ Stars = Premium)Hospice & Palliative9.0x – 12.5x EBITDAALOS (Average Length of Stay) & CensusPrivate Duty (Non-Med)3.5x – 4.5x SDE / 6x–8x EBITDACaregiver Retention & Recruitment TechABA & Behavioral7.0x – 10.0x EBITDAUtilization Rates & Credentialing Speed
3. Sophisticated Deal Structures in 2026
A "10x Multiple" is often a hybrid of cash, debt, and future promises. We are seeing three primary structures this year:
The "Clinical Quality" Earn-out: A portion of the price is held back for 12–24 months, contingent on maintaining Star Ratings or passing post-close audits with zero deficiencies.
Rollover Equity (The "Second Bite"): PE groups often require sellers to keep 10%–20% equity. When the firm sells the consolidated group 4 years later, that 20% can be worth more than the initial cash exit.
Seller Notes with PIK Interest: We frequently use PIK (Payment-in-Kind) Interest, where interest is added to the principal, increasing the seller's total payout at final maturity.
4. 2026 Value Killers: What Drops Your Multiple?
ADR (Additional Development Requests): Excessive Medicare audits signal high risk.
High Caregiver Turnover: Losing more than 50% of staff annually is a massive red flag.
Payor Concentration: If 80% of revenue comes from a single Managed Care contract.
Poor Documentation: Clinical notes that won't stand up to a rigorous Quality of Earnings (QofE) review.
Conclusion: Engineering the Premium Exit
At Home Care Business Broker, we don't just list businesses; we curate exits. By leveraging the resources of our parent firm, SeaRidge Advisory, and our operational experts at The Alignment Firm, we ensure your agency is positioned for the highest possible multiple.
Don't leave your legacy to chance. Understand your market value today.